An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects

• Status: Completed
• Trial end date: 2010-01-01

Summary

A three-month evaluation comparing the safety and efficacy of a fixed combination of 0.2% brimonidine tartrate/0.5% timolol maleate with that of latanoprost 0.005%, a prostaglandin analogue in glaucoma or ocular hypertension subjects

• Phase: Phase 4

Details

• Lead Sponsor: Allergan
• Treatments: Brimonidine Tartrate; Latanoprost; Maleic acid; Ophthalmic Solutions; Pharmaceutical Solutions; Timolol